Congress

Words from the US president make a global impact, and some of Trump's words about the drug war have been among the worst.

Attorney General Sessions' announcement last week of a possible renewed war on marijuana continues to reverberate, the New Hampshire House passes a bill to legalize possession and cultivation, but not sales; Colorado lawmakers want a safe injection site as part of their response to the opioid crisis, and more.

The attorney general may have done us a favor by heightening the contradictions of federal marijuana prohibition.

The attorney general's war on marijuana proves unpopular, marijuana proves popular (again), Vermont moves forward on a legalization bill, and more.

The world's largest legal marijuana market is about to open for business, a New Hampshire legalization bill should get a vote next Wednesday, federal representatives ask the FDA to back away from its public health warning on kratom, and more.

As Drug War Chronicle marks the publication of its 1,000th issue, we reflect on what has changed and what hasn't in the past couple of decades. This piece recounts our domestic drug policy evolution in the US. A companion piece looks at the international picture.

It was the best of times; it was the worst of times. Tens of thousands die of drug overdoses, hundreds of thousands get arrested for drugs, yet marijuana is seeing boom times. As we bid adieu to 2017, here are the year's drug policy highlights.

Congress extended Rohrabacher-Blumenauer protections for another few weeks, the VA will now let doctors discuss -- but not recommend -- medical marijuana, a Utah poll has strong support for a medical marijuana initiative, and more.

Congress reauthorizes the federal ban on funding to prosecute medical marijuana in states where it is legal, Massachusetts regulators approve draft rules for the legal marijuana industry, and more.